With 35 years pharmaceutical, biotech and medtech experience gained in commercial, product development, supply chain, strategic leadership and corporate executive roles, Simon is a serial entrepreneur in early stage healthcare businesses. As CEO of ApaTech Ltd, a QMUL spinout, he developed a world leader in orthobiologics prior to its sale to Baxter for $330m in March 2010.
Prior to joining ApaTech in 2004 Simon was a Main Board Director of Celltech Group plc, serving as CEO, Celltech Pharmaceuticals, prior to which he served as COO of Vanguard Medica (later Vernalis plc). The early part of his career was spent at Glaxo/Glaxo Wellcome plc in a series of senior UK and international commercial, supply chain and strategic development leadership roles.
He is currently Chairman of investee companies Veryan Medical Ltd and Ieso Digital Health Ltd and a Non-Executive Director of Abingdon Health Ltd. In addition, Simon is Chairman of Calon Cardio-Technology Ltd and OssDsign AB and a Non-Executive Director of ReNeuron plc. In 2016 Simon was awarded the OBE for services to the healthcare business sector.